|
Market Closed -
Nasdaq Stockholm
00:00:00 18/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 2.030 SEK | +4.10% |
|
+6.56% | +6.84% |
| 07-20 | Enzymatica CFO Holger Lembrér buys shares for 110,000 kronor | FW |
| 07-16 | Enzymatica AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 473M 409M 383M 349M 657M 45.26B 666M 4.49B 1.76B 22.67B 1.78B 1.74B 75.42B | P/E 2024 |
-5.73x | P/E 2025 | -8.89x |
|---|---|---|---|---|---|
| Enterprise Value | 441M 381M 357M 325M 612M 42.19B 620M 4.19B 1.64B 21.14B 1.66B 1.62B 70.31B | EV / Sales 2024 |
5.88x | EV / Sales 2025 | 7.96x |
| Free-Float |
56.66% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +4.10% | ||
| 1 week | +6.56% | ||
| Current month | +9.43% | ||
| 1 month | -7.73% | ||
| 3 months | -18.15% | ||
| 6 months | +23.40% | ||
| Current year | +6.84% |
| 1 week | 1.86 |  | 2.1 |
| 1 month | 1.61 | | 2.25 |
| Current year | 1.6 | | 3.4 |
| 1 year | 1.6 | | 3.4 |
| 3 years | 1.34 | | 5.45 |
| 5 years | 1.34 | | 12 |
| 10 years | 1.34 | | 24.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sana Alajmovic
CEO | Chief Executive Officer | - | 01/02/2026 |
Ulf Thomas Blom
COO | Chief Operating Officer | 61 | 01/01/2011 |
Holger Lembrér
DFI | Director of Finance/CFO | - | 13/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 58 | 15/02/2016 | |
Bengt Baron
CHM | Chairman | 64 | 19/12/2016 |
| Director/Board Member | 71 | 19/12/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 17/7/26 | Buy | Chief Financial Officer | 50,000 | 0.0206% | ||
| 30/12/25 | Buy | Chairman | 20,000 | 0.0082% | ||
| 27/12/25 | Buy | Chairman | 5,500 | 0.0023% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.10% | +6.56% | -18.80% | -18.31% | 49.77M | |
| +1.05% | -3.14% | +70.93% | +121.92% | 1,052B | |
| +0.98% | +0.44% | +49.20% | +51.12% | 627B | |
| +0.24% | +0.92% | +21.14% | +66.80% | 441B | |
| +0.28% | -4.56% | +39.10% | +38.05% | 349B | |
| +0.78% | -2.68% | +23.13% | +37.32% | 287B | |
| +0.87% | -3.59% | -1.52% | +7.12% | 241B | |
| +0.54% | +0.04% | +42.63% | +58.18% | 224B | |
| -0.78% | -4.49% | -15.86% | -54.13% | 202B | |
| +0.37% | +4.25% | +17.56% | +81.32% | 172B | |
| Average | +0.72% | -0.29% | +22.75% | +38.94% | 359.52B | |
| Weighted average by Cap. | +0.55% | -0.63% | +40.09% | +64.41% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 45.58M 39.34M 36.91M 33.62M 63.22M 4.36B 64.09M 433M 170M 2.18B 171M 167M 7.26B | 53.9M 46.53M 43.66M 39.76M 74.77M 5.15B 75.8M 512M 201M 2.58B 202M 198M 8.59B |
| Net income | -53.18M -45.91M -43.07M -39.23M -73.76M -5.08B -74.79M -505M -198M -2.55B -200M -195M -8.47B | -51.89M -44.8M -42.03M -38.28M -71.98M -4.96B -72.97M -493M -193M -2.49B -195M -191M -8.27B |
| Net Debt | -73.01M -63.03M -59.13M -53.86M -101M -6.98B -103M -693M -272M -3.5B -274M -268M -11.63B | -32.11M -27.72M -26.01M -23.69M -44.54M -3.07B -45.16M -305M -119M -1.54B -121M -118M -5.12B |
Employees
18
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/08/26 | SEK 2.030 | +4.10% | 48,825 |
| 14/08/26 | SEK 1.950 | -4.88% | 133,767 |
| 13/08/26 | SEK 2.050 | +4.86% | 80,161 |
| 12/08/26 | SEK 1.955 | +3.17% | 77,530 |
| 11/08/26 | SEK 1.895 | -0.52% | 23,993 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- ENZY Stock
Select your edition
All financial news and data tailored to specific country editions
